Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results

World News: . []

SAN DIEGO March 13 2018 GLOBE NEWSWIRE -- Vital Therapies Inc (Nasdaq:VTL), a biotherapeutic company developing ELADreg a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for the fourth quarte...

More news and information about Vital Therapies, Inc.

Published By:

Globe Newswire: 20:01 GMT Tuesday 13th March 2018

Published: .

Search for other references to "vital" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
Privacy Policy | Terms and Conditions | Contact Us